BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27532155)

  • 1. A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma.
    Yusuf AA; Natwick T; Werther W; Felici D; Mahue M; Bridges KR; Peng Y
    Curr Med Res Opin; 2016 Dec; 32(12):1989-1996. PubMed ID: 27532155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes Associated With Chronic Kidney Disease in Elderly Medicare Patients With Multiple Myeloma.
    Li S; Gong T; Kou C; Fu A; Bolanos R; Liu J
    Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):401-412.e24. PubMed ID: 33658169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma.
    Leng S; Chen Y; Tsai WY; Bhutani D; Hillyer GC; Lim E; Accordino MK; Wright JD; Hershman DL; Lentzsch S; Neugut AI
    J Natl Compr Canc Netw; 2019 Jan; 17(1):22-28. PubMed ID: 30659126
    [No Abstract]   [Full Text] [Related]  

  • 4. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort.
    Chen Y; Lairson DR; Chan W; Du XL
    Med Oncol; 2017 Sep; 34(9):153. PubMed ID: 28776319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare fee-for-service enrollees with primary acute myeloid leukemia: an analysis of treatment patterns, survival, and healthcare resource utilization and costs.
    Meyers J; Yu Y; Kaye JA; Davis KL
    Appl Health Econ Health Policy; 2013 Jun; 11(3):275-86. PubMed ID: 23677706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality by a proxy performance status as defined by a claims-based measure for disability status in older patients with newly diagnosed multiple myeloma in the United States.
    Li S; Natwick T; Liu J; Morrison VA; Vidito S; Werther W; Yusuf AA; Usmani SZ
    J Geriatr Oncol; 2019 May; 10(3):490-496. PubMed ID: 30709612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
    Zagouri F; Kastritis E; Zomas A; Terpos E; Katodritou E; Symeonidis A; Delimpasi S; Pouli A; Vassilakopoulos TP; Michalis E; Giannouli S; Kartasis Z; Christoforidou A; Kokoviadou K; Hatzimichael E; Gika D; Megalakaki C; Papaioannou M; Kyrtsonis MC; Konstantopoulos K; Dimopoulos MA;
    Eur J Haematol; 2017 Nov; 99(5):409-414. PubMed ID: 28675766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures.
    Flum DR; Salem L; Elrod JA; Dellinger EP; Cheadle A; Chan L
    JAMA; 2005 Oct; 294(15):1903-8. PubMed ID: 16234496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma.
    Mian HS; Wildes TM; Fiala MA
    JCO Clin Cancer Inform; 2018; 2():. PubMed ID: 30547157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk of hypertension in patients newly treated for multiple myeloma: a retrospective cohort study.
    Chari A; Mezzi K; Zhu S; Werther W; Felici D; Lyon AR
    BMC Cancer; 2016 Nov; 16(1):912. PubMed ID: 27876016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma.
    Chen Y; Lairson DR; Chan W; Du XL
    Ann Hematol; 2018 May; 97(5):851-863. PubMed ID: 29333596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.
    Yashkin AP; Hahn P; Sloan FA
    Ophthalmology; 2016 Oct; 123(10):2225-31. PubMed ID: 27523614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of mortality in older adults with loss of appetite: An analysis of Medicare fee-for-service data.
    Dagenais S; Clark S; Fielding RA; Cantu C; Prasad S; Dai F; Groarke JD
    J Nutr Health Aging; 2024 Mar; 28(3):100035. PubMed ID: 38308921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Socioeconomic Characteristics and Comorbidities on Therapy Initiation and Outcomes of Newly Diagnosed Multiple Myeloma: Real-World Data From a Resource-Constrained Setting.
    Vargas-Serafin C; Acosta-Medina AA; Ordonez-Gonzalez I; Martínez-Baños D; Bourlon C
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):182-187. PubMed ID: 33414064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of multiple myeloma in Taiwan, a population based study.
    Tang CH; Liu HY; Hou HA; Qiu H; Huang KC; Siggins S; Rothwell LA; Liu Y
    Cancer Epidemiol; 2018 Aug; 55():136-141. PubMed ID: 29957398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
    Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
    Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
    Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
    BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
    Kim SM; Kim MJ; Jung HA; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
    Biomed Res Int; 2014; 2014():437852. PubMed ID: 25114902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.